Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Redmile Group has bolstered its stake in Krystal Biotech with a $3.43 million purchase. This move signals confidence in Krystal's strategic push into gene therapy for rare diseases. What does this mean for the future of biotech investments?